PIGV

protein-coding

phosphatidylinositol glycan anchor biosynthesis class V, the group of Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis

Gene summary

This gene encodes a mannosyltransferase enzyme involved in the biosynthesis of glycosylphosphatidylinositol (GPI). GPI is a complex glycolipid that functions as a membrane anchor for many proteins and plays a role in multiple cellular processes including protein sorting and signal transduction. The encoded protein is localized to the endoplasmic reticulum and transfers the second mannose to the GPI backbone. Mutations in this gene are associated with hyperphosphatasia cognitive disability syndrome. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Feb 2011]

MANE transcript

NM_017837.4

Inheritance

AR

ClinVar variants

P:20U:195B:140

Top phenotype

Hyperphosphatasia with impaired intellectual development syndrome 1

gnomAD constraint

pLI —, LoF o/e 0.79

Max pathogenic AF

—

Genomic locus

chr1:26,787,054-26,800,659

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~13.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

hyperphosphatasia with impaired intellectual development syndrome 1MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0009398

Submitter: Ambry Genetics

hyperphosphatasia with impaired intellectual development syndrome 1DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009398

Submitter: G2P

hyperphosphatasia-intellectual disability syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0016596

Submitter: Orphanet

hyperphosphatasia with impaired intellectual development syndrome 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009398

Submitter: PanelApp Australia

hyperphosphatasia with impaired intellectual development syndrome 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009398

Submitter: Labcorp Genetics (formerly Invitae)

hyperphosphatasia with impaired intellectual development syndrome 1MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0009398

Submitter: ClinGen

*PIGV* was first reported in relation to autosomal recessive hyperphosphatasia with intellectual disability syndrome 1 in 2010 (Krawitz et al., PMID: 20802478). 14 unique variants (13 missense, 1 nonsense) that have been reported in 18 probands in 8 publications (PMIDs: 20802478, 21739589, 22315194, 24129430, 27177984, 28688840, 28817240, 37863628) are included in this curation. One recurrent variant in the European population (NM_017837.4:c.1022C>A, p.Ala341Glu) has been observed in the homozygous state in 5 probands and in the compound heterozygous state in 9 probands. The mechanism of pathogenicity appears to be loss of function, although most variants reported in conjunction with this condition are missense variants without functional studies. This gene-disease relationship is also supported by a mouse knock-in model and a Chinese hamster ovary cell knockout model (PMIDs: 33402532, 22228761). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date June 18, 2025 (SOP Version 11).

Clinical Genomic Database (CGD)

Hyperphosphatasia with impaired intellectual development syndrome 1AR

Manifestation: Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Gastrointestinal; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 5465362; 1724113; 16638507; 17351347; 20080219; 20802478; 20578257; 21739589; 22315194Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PIGV variants in ClinVar

7 Conditions Cataloged
not providedTotal: 305
Inborn genetic diseasesTotal: 76
Hyperphosphatasia with intellectual disability syndrome 1Total: 51
not specifiedTotal: 39
PIGV-related disorderTotal: 16
Hyperphosphatasia-intellectual disability syndromeTotal: 1
Elevated circulating alkaline phosphatase concentrationTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_017837.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
127
clinvar
130
missense
3
clinvar
9
clinvar
176
clinvar
13
clinvar
201
nonsense
5
clinvar
5
clinvar
10
start loss
0
frameshift
2
clinvar
11
clinvar
13
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total3171951400355

Highest pathogenic variant AF is 0.00012452883

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 86 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_017837.4RefSeqNP_060307.23MANE Select
ENST00000674202.1EnsemblENSP00000501479.13MANE Select
NM_001202554.2RefSeqNP_001189483.13Standard
NM_001374478.1RefSeqNP_001361407.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
  • Vitamin B6-dependent and responsive disorders
  • Synthesis of glycosylphosphatidylinositol (GPI)
  • Post-translational modification: synthesis of GPI-anchored proteins
  • Post-translational protein modification

Biological Process

  • GPI anchor biosynthetic process
  • preassembly of GPI anchor in ER membrane
  • mannosylation

Molecular Function

  • mannosyltransferase activity
  • glycolipid mannosyltransferase activity
  • dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity

Cellular Component

  • endoplasmic reticulum membrane
  • integral component of membrane
  • mannosyltransferase complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000374145
Coding exons
3
Length
10927
Individuals with no LoFs
125690
Homozygous LoFs
0
Heterozygous LoFs
58
Defined
125748
p
0.000231
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3982402580.9300.00001393169
Missense (PolyPhen)7893.6610.832791231
Synonymous0.2021061090.9750.000005821074
Loss of Function0.8111417.70.7929.52e-7190

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American0.0000870.000087rare
Ashkenazi Jewish0.000300.00030rare
East Asian0.000160.00016rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.000340.00034rare
South Asian0.000260.00026rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Alpha-1,6-mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the second mannose to the glycosylphosphatidylinositol during GPI precursor assembly. {ECO:0000269|PubMed:15623507, ECO:0000269|PubMed:15720390}.;
Disease
DISEASE: Hyperphosphatasia with mental retardation syndrome 1 (HPMRS1) [MIM:239300]: A severe syndrome characterized by elevated serum alkaline phosphatase, severe mental retardation, seizures, hypotonia, facial dysmorphism, and hypoplastic terminal phalanges. {ECO:0000269|PubMed:20802478}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.258
RVIS EVS
-0.4
RVIS percentile EVS
26.73

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
E
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.465

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.